Firmonertinib mesylate

AbMole BioScience

Firmonertinib mesylate

9

2130958-55-1

Research Use Only

C29H35F3N8O5S

664.7

Firmonertinib (Alflutinib) mesylate is a potent, third generation EGFR inhibitor that targets both EGFR activating mutations and T790M thus leading to tumor growth inhibition. Firmonertinib (AST2818) has the potential for the research of non-small cell lung cancer (NSCLC).

CN(C)CCN(C)C1=NC(=C(NC2=NC=CC(=N2)C3=C[N](C)C4=CC=CC=C34)C=C1NC(=O)C=C)OCC(F)(F)F.C[S](O)(=O)=O

4°C, dry, sealed

12352200